Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) is set to release its Q3 2025 earnings on Jan 31, 2025. The consensus ...

Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call. My name ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

It is expected that representatives for MSMEs pharma manufacturers may raise the issue of extension of Revised Schedule M implementation timelines ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

The growing use of AI has opened new avenues for healthcare marketers, revolutionising how they approach new initiatives. With the Pharma 4.0 term representing the pharmaceutical industry's adaptation ...

Sen. Ron Johnson (R-WI) on the second day of Robert F. Kennedy's confirmation hearing expressed his displeasure with the ...